Behavioural activation for depressive symptoms in adults with severe to profound intellectual disabilities: Modelling and initial feasibility study

Background Almost no research has been published reporting on evaluations of the effectiveness of psychological interventions for people with severe to profound intellectual disabilities and depression. This paper describes the development and initial feasibility testing of an adapted Behavioural Ac...

Full description

Saved in:
Bibliographic Details
Published in:Journal of applied research in intellectual disabilities 2024-03, Vol.37 (2), p.e13197-n/a
Main Authors: Gillooly, Amanda, Dagnan, Dave, Hastings, Richard, Hatton, Chris, McMeekin, Nicola, Baines, Susie, Cooper, S.‐A., Crawford, Lucy, Gillespie, David, Miller, Jenny, Jahoda, Andrew
Format: Article
Language:English
Subjects:
Adult
Adults
Behavior modification
Behavior Therapy
behavioural activation
depression
Depression - therapy
Feasibility Studies
feasibility study
Humans
Intellectual disabilities
Intellectual Disability - psychology
Mental depression
psychological therapy
Psychotherapy
severe intellectual disability
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Almost no research has been published reporting on evaluations of the effectiveness of psychological interventions for people with severe to profound intellectual disabilities and depression. This paper describes the development and initial feasibility testing of an adapted Behavioural Activation therapy (BeatIt2) for this population. Method Phase 1 of the study examined participant recruitment and willingness to be randomised in the context of a planned Randomised Controlled Trial (RCT). Phase 2 examined the feasibility of delivering the intervention. Results Twenty adults with a severe or profound intellectual disability and clinically significant depression were recruited to Phase 1 of the study. In Phase 2, there was 100% participant retention for those recruited to the study at 6‐month follow‐up. The BeatIt2 therapy was reported to be acceptable for participants. Conclusion COVID disruption meant that it was not possible to complete the planned feasibility RCT. The positive findings suggest that additional evaluation of BeatIt2 is warranted.
ISSN:1360-2322
1468-3148
DOI:10.1111/jar.13197